The role of intratumoral and systemic IL-6 in breast cancer Christine DethlefsenGrith HøjfeldtPernille Hojman Review 27 March 2013 Pages: 657 - 664
Trends in breast cancer incidence and mortality in the United States: implications for prevention Adetunji T. ToriolaGraham A. Colditz Review 02 April 2013 Pages: 665 - 673
The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis M. JohannsenI. FarverR. Zachariae Review 04 April 2013 Pages: 675 - 690
A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories Borbala SzekelyTakayuki IwamotoLajos Pusztai Preclinical study 17 March 2013 Pages: 691 - 698
Effect of selumetinib on the growth of anastrozole-resistant tumors Gauri J. SabnisArmina KaziAngela Brodie Preclinical study 19 March 2013 Pages: 699 - 708
MicroSPECT/CT imaging of co-expressed HER2 and EGFR on subcutaneous human tumor xenografts in athymic mice using 111In-labeled bispecific radioimmunoconjugates Eva RazumienkoLindsay DrydenRaymond M. Reilly Preclinical study 24 March 2013 Pages: 709 - 718
Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast David P. ArpsPatrick HealyJudy C. Pang Preclinical study 28 March 2013 Pages: 719 - 726
Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling Amita SnehYadwinder S. DeolRamesh K. Ganju Preclinical Study 28 March 2013 Pages: 727 - 739
EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis Heather M. MooreMaria E. GonzalezCelina G. Kleer Preclinical study 29 March 2013 Pages: 741 - 752
Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers Avital GilamLiat EdryNoam Shomron Preclinical Study 03 April 2013 Pages: 753 - 760
Genomic and expression analysis of microdissected inflammatory breast cancer Wendy A. WoodwardSavitri KrishnamurthyNaoto T. Ueno Preclinical study 09 April 2013 Pages: 761 - 772
Phosphorylation of AKT pathway proteins is not predictive of benefit of taxane therapy in early breast cancer John M. S. BartlettRoger A’HernPeter J. Barrett-Lee Clinical trial 28 March 2013 Pages: 773 - 781
The use of neoadjuvant platinum-based chemotherapy in locally advanced breast cancer that is triple negative: retrospective analysis of 144 patients Judith HurleyIsildinha M. ReisMark D. Pegram Clinical Trial 31 March 2013 Pages: 783 - 794
Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors Dawn L. HershmanHeather GreenleeKatherine D. Crew Clinical trial 31 March 2013 Pages: 795 - 806
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer N. Lynn HenryTodd C. SkaarDavid A. Flockhart Clinical trial 02 April 2013 Pages: 807 - 816
International multicenter tool to predict the risk of four or more tumor-positive axillary lymph nodes in breast cancer patients with sentinel node macrometastases Tuomo J. MeretojaR. A. AudisioM. H. K. Leidenius Clinical Trial 05 April 2013 Pages: 817 - 827
nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis Joyce O’ShaughnessyWilliam J. GradisharJose Iglesias Clinical Trial Open access 06 April 2013 Pages: 829 - 837
Health economic impact of risk group selection according to ASCO-recommended biomarkers uPA/PAI-1 in node-negative primary breast cancer Volker R. JacobsRonald E. KatesNadia Harbeck Clinical Trial 09 April 2013 Pages: 839 - 850
Ultrasonographic assessment of breast density Won Hwa KimWoo Kyung MoonEun Hee Lee Clinical Trial 09 April 2013 Pages: 851 - 859
Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy L. OttiniV. SilvestriD. Palli Epidemiology 07 March 2013 Pages: 861 - 868
Cumulative risk of cancer detection in breast cancer screening by protocol strategy J. BlanchM. SalaCFPR group Epidemiology 08 March 2013 Pages: 869 - 877
Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography Rebecca A. HubbardWeiwei ZhuAlison Sweet Epidemiology 08 March 2013 Pages: 879 - 887
Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women Anne Marie McCarthyKatrina ArmstrongSusan M. Domchek Epidemiology 10 March 2013 Pages: 889 - 898
Prognostic relevance of Ki-67 in the primary tumor for survival after a diagnosis of distant metastasis Christian R. LoehbergKatrin AlmstedtDavid L. Wachter Epidemiology 12 March 2013 Pages: 899 - 908
The influence of adjuvant therapy on cardiorespiratory fitness in early-stage breast cancer seven years after diagnosis: the Cooper Center Longitudinal Study Susan G. LakoskiCarolyn E. BarlowLee W. Jones Epidemiology 17 March 2013 Pages: 909 - 916
Prognostic value of single nucleotide polymorphisms of candidate genes associated with inflammation in early stage breast cancer James L. MurrayPatricia ThompsonAbenaa M. Brewster Epidemiology 26 March 2013 Pages: 917 - 924
Intake of specific fruits and vegetables in relation to risk of estrogen receptor-negative breast cancer among postmenopausal women Teresa T. FungStephanie E. ChiuveMichelle D. Holmes Epidemiology 27 March 2013 Pages: 925 - 930
Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer Christopher R. FrieseT. May PiniJennifer J. Griggs Epidemiology 31 March 2013 Pages: 931 - 939
Impact of recent parity on histopathological tumor features and breast cancer outcome in premenopausal Japanese women Akiko Kawano NagatsumaChikako ShimizuYasuhiro Fujiwara Epidemiology 04 April 2013 Pages: 941 - 950
Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study Paolo ContieroFranco BerrinoPaola Muti Epidemiology 09 April 2013 Pages: 951 - 959
A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer Pui San TanBenjamin HaalandGilberto Lopes Brief Report 31 March 2013 Pages: 961 - 965
Differences in vitamin D levels may contribute to racial disparities in breast cancer William B. Grant Letter to the Editor 19 March 2013 Pages: 967 - 968
Melatonin and its contribution to tumor attenuation in systemic malignancies Shailendra Kapoor Letter to the Editor 29 March 2013 Pages: 969 - 970
Erratum to: Impact of breast cancer on anti-mullerian hormone levels in young women H. I. SuS. W. FlattA. Z. Steiner Erratum 28 March 2013 Pages: 975 - 975
Retraction Note: Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL Charitha GangadharanMaikho ThohSunil Kumar Manna Retraction Note 24 March 2013 Pages: 977 - 977